What Happened?
Shares of pharmaceutical company Amphastar Pharmaceuticals (NASDAQAMPH) jumped 3.7% in the afternoon session after positive analyst sentiment and technical trading indicators pointed to potential upside for the stock. The cautiously optimistic view from analysts included three buy ratings and three hold ratings, with no sell recommendations. The average price target was set at $32.00, reflecting a potential upside. Adding to the positive tone, insider sentiment was reported as positive, based on the timing of recent acquisitions. The stock also traded above its key 50-day and 200-day moving averages, a signal some investors viewed favorably.
After the initial pop the shares cooled down to $27.55, up 3.3% from previous close.
Is now the time to buy Amphastar Pharmaceuticals? Access our full analysis report here.
What Is The Market Telling Us
Amphastar Pharmaceuticals’s shares are somewhat volatile and have had 14 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business.
The previous big move we wrote about was 12 days ago when the stock gained 3.2% on the news that comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated he sees “room for a further adjustment” in the near term, sparking a significant market rally. Following his remarks, the probability of the central bank cutting rates at its December meeting jumped from 39% to over 73%, according to the CME FedWatch tool. This positive sentiment provided relief to markets amid concerns over high valuations, particularly in AI-related stocks.
Amphastar Pharmaceuticals is down 24.2% since the beginning of the year, and at $27.55 per share, it is trading 38.7% below its 52-week high of $44.92 from December 2024. Investors who bought $1,000 worth of Amphastar Pharmaceuticals’s shares 5 years ago would now be looking at an investment worth $1,486.
Do you want to know what moves the business you care about? Add them to your StockStory watchlist and every time a stock significantly moves, we provide you with a timely explanation straight to your inbox. It’s free for active Edge members and will only take you a second.